Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cytosorbents Corp Director's Dealing 2017

Jun 6, 2017

34501_dirs_2017-06-06_27954c79-14d1-413f-a703-f7a3d55fdc4a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2017-06-06

Reporting Person: Mortensen Eric R. (Chief Medical Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct